Personalized blood test pinpoints early breast cancer in preliminary study

A new method for capturing circulating tumor DNA in the bloodstream underpins a highly precise blood test for tracking the early progression of breast cancer—which its developers say could be up to 100 times more sensitive than current tests.

Sourced through Scoop.it from: www.fiercebiotech.com